Effect of addition of G-CSF injection on level of hemoglobin in patients recieving hemodialysis who are unresponsive to erythropoietin injection.
Phase 4
- Conditions
- Health Condition 1: N186- End stage renal disease
- Registration Number
- CTRI/2019/04/018545
- Lead Sponsor
- AIIMS Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
CKD-on Hemodialysis, receiving ESA at least 4 weeks with
1)baseline HB <10 g/dl
2)no increase in Hb or increase Hb <2% from baseline after 4 week of weight based ESA therapy
3)age >18 years
Exclusion Criteria
1) Pregnancy
2) Patient not willing to give consent for the study
3) Known allergy to G-CSF
4) Age < 18 years, >70 years
5) Thrombocytopenia
6) Sepsis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method